Compare XBIT & PLBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XBIT | PLBC |
|---|---|---|
| Founded | 2005 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.5M | 288.9M |
| IPO Year | 2015 | 2005 |
| Metric | XBIT | PLBC |
|---|---|---|
| Price | $2.40 | $45.45 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $55.00 |
| AVG Volume (30 Days) | ★ 73.6K | 17.9K |
| Earning Date | 11-12-2025 | 01-14-2026 |
| Dividend Yield | N/A | ★ 2.64% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.23 |
| Revenue | N/A | ★ $89,868,000.00 |
| Revenue This Year | N/A | $21.11 |
| Revenue Next Year | N/A | $16.11 |
| P/E Ratio | ★ N/A | $10.77 |
| Revenue Growth | N/A | ★ 12.51 |
| 52 Week Low | $2.09 | $38.71 |
| 52 Week High | $7.24 | $49.63 |
| Indicator | XBIT | PLBC |
|---|---|---|
| Relative Strength Index (RSI) | 48.15 | 71.08 |
| Support Level | $2.15 | $43.50 |
| Resistance Level | $2.65 | $45.71 |
| Average True Range (ATR) | 0.15 | 0.80 |
| MACD | 0.02 | 0.25 |
| Stochastic Oscillator | 33.33 | 95.70 |
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.
Plumas Bancorp provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.